CancerPPD

This page gives details of Query peptides and provides facility to browse the same in CancerPPD database. Please wait while data is being retrieved. For more information see HELP page.

ID	PMID	SEQUENCE	NAME	LENGTH	ACTIVITY
1667	15796184	LRVRLASHLRKLRKRLLRDADDLQKRLAVY	Apo E	30	60 % Cytotoxity at 40 µg/ml
1668	15796184	LRVRLASHLRKLRKRLLRDADDLQKRLAVY	Apo E	30	35 % Cytotoxity at 40 µg/ml
1686	22641352	LLRHVVKILEKYL	Temporin-La	13	48.19 Inhibition ratio at 50 µg/ml
1687	22641352	LLRHVVKILSKYL	Temporin-Las	13	50.85 Inhibition ratio at 50 µg/ml
1688	22641352	RGDLLRHVVKILEKYL	RGD-La	16	62.49 Inhibition ratio at 50 µg/ml
1689	22641352	RGDLLRHVVKILSKYL	RGD-Las	16	73.705 Inhibition ratio at 50 µg/ml
1713	None	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	IC₅₀ = 26.7 mM
1719	None	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	IC₅₀ = 22.51 mM
1725	None	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	IC₅₀ = 24.31 mM
1731	None	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	IC₅₀ = 13.77 mM
1744	None	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	IC₅₀ = 26.7 mM
1752	None	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	IC₅₀ = 22.51 mM
1760	None	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	IC₅₀ = 22.31 mM
1768	None	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	IC₅₀ = 13.77 mM
3090	16004618	MRKEFHNVLSSGQLLADKRPARDYNRK	Pep27	27	IC₅₀= >70 µM
3091	16004618	MWKWFHNVLSSWQLLADKRPARDYNRK	Pep27anal1	27	IC₅₀= 37 µM
3092	16004618	MWKWFHNVLSWWWLLADKRPARDYNRK	Pep27anal2	27	IC₅₀= 25 µM
3093	16004618	MRKWFHNVLSSGQLLADKWPAWDYNRK	Pep27anal3	27	IC₅₀= 50 µM
3094	16004618	MWKEFHNVLSSGQLLADKRWARWYNRW	Pep27anal4	27	IC₅₀= 37 µM
3095	16004618	MWKWFHNVLSSGQLLADKWWAWWYNWW	Pep27anal5	27	IC₅₀=>70 µM
3106	22783018	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	<100% cell viability at 5 µM
3107	22783018	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	<20% cell viability at 50 µM
3112	22783018	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	<100% cell viability at 5 µM
3113	22783018	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	<40% cell viability at 50 µM
3229	22644847	FLGWLFKWAWK	GA-W3	11	IC₅₀ =24.31 µM
3236	22644847	FLWWLFKWAWK	GA-W4	11	IC₅₀ =13.77 µM
3243	22644847	FLGWLFKWAKK	GA-K3	11	IC₅₀ =26.70 µM
3250	22644847	FLKWLFKWAKK	GA-K4	11	IC₅₀ =22.51 µM
3258	22783018	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	<100% cell viability at 5 µM
3259	22783018	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	<20% cell viability at 50 µM
3264	22783018	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	100% cell viability at 5 µM
3265	22783018	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	<40% cell viability at 50 µM
3354	None	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	~80% survival rate at 10 µM
3355	None	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	10% survival rate at 100 µM
3360	None	KWKKLLKKPPPLLKKLLKKL	Synthetic peptide	20	~20% survival rate at 10 µM
3361	None	KWKKLLKKPPPLLKKLLKKL	Synthetic peptide	20	0% survival rate at 100 µM
3730	22644847	FLGWLFKWAWK	GA-W3	11	IC₅₀= 24.31 µM
3737	22644847	FLWWLFKWAWK	GA-W4	11	IC₅₀= 13.77 µM
3744	22644847	FLGWLFKWAKK	GA-K3	11	IC₅₀= 26.70 µM
3751	22644847	FLKWLFKWAKK	GA-K4	11	IC₅₀= 22.51 µM
4601	15496597	KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL	CB	36	Not Available
5057	24714081	TKPRKTKPRKTKPRKTKPR	T Peptide	19	67.2% maximum inhibitory rate at 8 mg/kg

CancerPPD :Database of Anticancer peptides and Proteins

Browse Result page of CancerPPD